Targeting glutamine metabolism and EGFR in RAS wildtype colorectal cancer

被引:1
|
作者
Ciombor, K. [1 ]
Whisenant, J. [1 ]
Ayers, G. [1 ]
Eng, C. [1 ]
Goff, L. [1 ]
Cardin, D. [1 ]
Hickman, T. [1 ]
Smith, G. [1 ]
Peterson, T. [1 ]
Bae, S. [2 ]
Das, S. [3 ]
Manning, H. [2 ]
Berlin, J. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] AstraZeneca, Gaithersburg, MD USA
关键词
D O I
10.1016/j.annonc.2023.04.243
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-187
引用
收藏
页码:S82 / S82
页数:1
相关论文
共 50 条
  • [1] Molecular imaging of glutamine (Gln) metabolism in RAS wildtype (WT) metastatic colorectal cancer (mCRC)
    Whisenant, Jennifer Gray
    Smith, Gary
    Cohen, Allison
    Ciombor, Kristen K.
    Cardin, Dana
    Eng, Cathy
    Goff, Laura
    Das, Satya
    Hickman, Tiffany
    Fisher, Anna
    Payne, Adria
    Coffey, Robert
    Ayers, G. Dan
    Berlin, Jordan D.
    Manning, H. Charles
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Targeting glutamine metabolism potentiates antigen presentation in colorectal cancer
    Yu, Tao
    Van der Jeught, Kevin
    Zhu, Haiqi
    Zhou, Zhuolong
    Sharma, Samantha
    Liu, Sheng
    So, Ka Man
    Eyvani, Haniyeh
    Wang, Xiyu
    Sandusky, George E.
    Liu, Yunlong
    Opyrchal, Mateusz
    Cao, Sha
    Wan, Jun
    Zhang, Chi
    Zhang, Xinna
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer
    Cohen, Allison S.
    Geng, Ling
    Zhao, Ping
    Fu, Allie
    Schulte, Michael L.
    Graves-Deal, Ramona
    Washington, M. Kay
    Berlin, Jordan
    Coffey, Robert J.
    Manning, H. Charles
    TRANSLATIONAL ONCOLOGY, 2020, 13 (10):
  • [4] Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer
    Huang, Mofei
    Xiong, Donghai
    Pan, Jing
    Zhang, Qi
    Sei, Shizuko
    Shoemaker, Robert H.
    Lubet, Ronald A.
    Montuenga, Luis M.
    Wang, Yian
    Slusher, Barbara S.
    You, Ming
    ADVANCED SCIENCE, 2022, 9 (26)
  • [5] Targeting EGFR in colorectal cancer
    Messersmith, Wells A.
    Ahnen, Dennis J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17): : 1834 - 1836
  • [6] Targeting Glutamine Metabolism for Cancer Treatment
    Choi, Yeon-Kyung
    Park, Keun-Gyu
    BIOMOLECULES & THERAPEUTICS, 2018, 26 (01) : 19 - 28
  • [7] Targeting glutamine metabolism in breast cancer
    Korangath, Preethi C.
    Zhang, Huafeng
    Zhang, Zhe
    Huso, David
    Stearns, Vered
    Dang, Chi
    Semenza, Gregg
    Sukumar, Saraswati
    CANCER RESEARCH, 2011, 71
  • [8] Targeting BRAF and RAS in Colorectal Cancer
    Bellio, Helene
    Fumet, Jean David
    Ghiringhelli, Francois
    CANCERS, 2021, 13 (09)
  • [9] Anti-EGFR-based conversion chemotherapy in RAS wildtype colorectal cancer patients: Impact on survival and resection rates.
    Koch, Christine
    Schmidt, Niklas
    Winkelmann, Ria
    Eichler, Katrin
    Hansmann, Martin-Leo
    Bechstein, Wolf O.
    Pession, Ursula
    Zeuzem, Stefan
    Trojan, Jorg
    Waidmann, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Resistance mechanisms to anti-EGFR therapy in RAS/RAF wildtype colorectal cancer varies by regimen and line of therapy.
    Parseghian, Christine Megerdichian
    Sun, Ryan
    Woods, Melanie Nicole
    Napolitano, Stefania
    Alshenaifi, Jumanah
    Willis, Jason
    Nunez, ShaKayla Kentel
    Sorokin, Alexey
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Shen, John Paul Y. C.
    Sanchez, Eduardo Vilar
    Rehn, Marko
    Ang, Agnes
    Troiani, Teresa
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)